Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients

End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2015-05, Vol.10 (5), p.e0125089
Main Authors: Pladys, Adélaïde, Couchoud, Cécile, LeGuillou, Aurélie, Siebert, Muriel, Vigneau, Cécile, Bayat, Sahar
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Analysis
Cancer
Cancer therapies
Cardiovascular diseases
Chronic illnesses
Chronic kidney failure
Comorbidity
Complications and side effects
Death
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Dialysis
End-stage renal disease
Epidemiology
Female
France - epidemiology
Genetics
Health risks
Humans
Insulin resistance
Insulin-like growth factors
Kidney diseases
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Kidney transplantation
Life Sciences
Male
Middle Aged
Mortality
Neoplasms - etiology
Neoplasms - mortality
Patient outcomes
Patients
Peritoneal dialysis
Peritoneum
Retrospective Studies
Risk
Risk Factors
Santé publique et épidémiologie
Transplantation
Transplants & implants
Tumors
Type 2 diabetes
Vascular diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793
cites cdi_FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793
container_end_page
container_issue 5
container_start_page e0125089
container_title PloS one
container_volume 10
creator Pladys, Adélaïde
Couchoud, Cécile
LeGuillou, Aurélie
Siebert, Muriel
Vigneau, Cécile
Bayat, Sahar
description End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39,811 patients with end-stage renal disease. Their mean age was 67.7±15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p
doi_str_mv 10.1371/journal.pone.0125089
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1680430487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A431693326</galeid><doaj_id>oai_doaj_org_article_f30fb3c4808d4fa5b29ca67389427fe1</doaj_id><sourcerecordid>A431693326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793</originalsourceid><addsrcrecordid>eNqNk11r2zAUhs3YWLtu_2BshsFYYcn0ZVm6GYSyroFAYet2K2RZihUcK5XksuzXT07ckpReDIMkjp7zng_5ZNlbCKYQl_DLyvW-k-104zo9BRAVgPFn2SnkGE0oAvj5wfkkexXCCoACM0pfZieo4LRggJ5mq5vtRucwl12dx-GI8trKSkcddjYlO6V9vnY-ytbGbW67PDYJAwBN0sJz5Zp0mTuTY_6ZQZhfet2pZpBpt391nW9ktLqL4XX2wsg26Dfjfpb9uvx2c3E1WVx_n1_MFhNVIhonsIIFBApCXUCIGC41UiZlhCXSChaGV1IbQriuakx4DTnBlTKQVzjttOT4LHu_1920LoixTUFAygDBgLAyEfM9UTu5Ehtv19JvhZNW7AzOL4X00apWC4OBqbAiDLCaGFlUiCtJS8w4QaXRMGl9HaP11VrXKlXqZXskenzT2UYs3Z0gBDGGaBI43ws0j9yuZgsx2ACERUlZeTcE-zQG8-621yGKtQ1Kt63stOv3NXIKAEYJ_fAIfboTI7WUqVjbGZdyVIOomBEMKcd4l-L0CSp9tV5blf4_Y5P9yOH8yCExUf-JS9mHIOY_f_w_e_37mP14wDZatrEJru2jdV04BskeVN6F4LV56CwEYhif-26IYXzEOD7J7d3hYz443c8L_geLsRCW</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680430487</pqid></control><display><type>article</type><title>Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Pladys, Adélaïde ; Couchoud, Cécile ; LeGuillou, Aurélie ; Siebert, Muriel ; Vigneau, Cécile ; Bayat, Sahar</creator><contributor>Wong, Germaine</contributor><creatorcontrib>Pladys, Adélaïde ; Couchoud, Cécile ; LeGuillou, Aurélie ; Siebert, Muriel ; Vigneau, Cécile ; Bayat, Sahar ; Wong, Germaine</creatorcontrib><description>End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39,811 patients with end-stage renal disease. Their mean age was 67.7±15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p&lt;0.001) and also female gender, peritoneal dialysis, cardio-vascular disease and kidney transplantation were associated with decreased risk of death by cancer. In this French cohort of patients with end-stage renal disease, diabetes was not associated with a significant increased risk of dying from cancer. Studies on the incidence of cancer in patients with ESRD are now needed to evaluate the potential association between diabetes and specific malignancies in this population.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0125089</identifier><identifier>PMID: 25965806</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aged ; Aged, 80 and over ; Analysis ; Cancer ; Cancer therapies ; Cardiovascular diseases ; Chronic illnesses ; Chronic kidney failure ; Comorbidity ; Complications and side effects ; Death ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 1 - epidemiology ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Dialysis ; End-stage renal disease ; Epidemiology ; Female ; France - epidemiology ; Genetics ; Health risks ; Humans ; Insulin resistance ; Insulin-like growth factors ; Kidney diseases ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - therapy ; Kidney transplantation ; Life Sciences ; Male ; Middle Aged ; Mortality ; Neoplasms - etiology ; Neoplasms - mortality ; Patient outcomes ; Patients ; Peritoneal dialysis ; Peritoneum ; Retrospective Studies ; Risk ; Risk Factors ; Santé publique et épidémiologie ; Transplantation ; Transplants &amp; implants ; Tumors ; Type 2 diabetes ; Vascular diseases</subject><ispartof>PloS one, 2015-05, Vol.10 (5), p.e0125089</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Pladys et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2015 Pladys et al 2015 Pladys et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793</citedby><cites>FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793</cites><orcidid>0000-0002-4500-7869</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1680430487/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1680430487?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25965806$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-rennes.hal.science/hal-01157687$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Wong, Germaine</contributor><creatorcontrib>Pladys, Adélaïde</creatorcontrib><creatorcontrib>Couchoud, Cécile</creatorcontrib><creatorcontrib>LeGuillou, Aurélie</creatorcontrib><creatorcontrib>Siebert, Muriel</creatorcontrib><creatorcontrib>Vigneau, Cécile</creatorcontrib><creatorcontrib>Bayat, Sahar</creatorcontrib><title>Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39,811 patients with end-stage renal disease. Their mean age was 67.7±15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p&lt;0.001) and also female gender, peritoneal dialysis, cardio-vascular disease and kidney transplantation were associated with decreased risk of death by cancer. In this French cohort of patients with end-stage renal disease, diabetes was not associated with a significant increased risk of dying from cancer. Studies on the incidence of cancer in patients with ESRD are now needed to evaluate the potential association between diabetes and specific malignancies in this population.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cardiovascular diseases</subject><subject>Chronic illnesses</subject><subject>Chronic kidney failure</subject><subject>Comorbidity</subject><subject>Complications and side effects</subject><subject>Death</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 1 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Dialysis</subject><subject>End-stage renal disease</subject><subject>Epidemiology</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Genetics</subject><subject>Health risks</subject><subject>Humans</subject><subject>Insulin resistance</subject><subject>Insulin-like growth factors</subject><subject>Kidney diseases</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney transplantation</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Neoplasms - etiology</subject><subject>Neoplasms - mortality</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Peritoneal dialysis</subject><subject>Peritoneum</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Santé publique et épidémiologie</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Tumors</subject><subject>Type 2 diabetes</subject><subject>Vascular diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11r2zAUhs3YWLtu_2BshsFYYcn0ZVm6GYSyroFAYet2K2RZihUcK5XksuzXT07ckpReDIMkjp7zng_5ZNlbCKYQl_DLyvW-k-104zo9BRAVgPFn2SnkGE0oAvj5wfkkexXCCoACM0pfZieo4LRggJ5mq5vtRucwl12dx-GI8trKSkcddjYlO6V9vnY-ytbGbW67PDYJAwBN0sJz5Zp0mTuTY_6ZQZhfet2pZpBpt391nW9ktLqL4XX2wsg26Dfjfpb9uvx2c3E1WVx_n1_MFhNVIhonsIIFBApCXUCIGC41UiZlhCXSChaGV1IbQriuakx4DTnBlTKQVzjttOT4LHu_1920LoixTUFAygDBgLAyEfM9UTu5Ehtv19JvhZNW7AzOL4X00apWC4OBqbAiDLCaGFlUiCtJS8w4QaXRMGl9HaP11VrXKlXqZXskenzT2UYs3Z0gBDGGaBI43ws0j9yuZgsx2ACERUlZeTcE-zQG8-621yGKtQ1Kt63stOv3NXIKAEYJ_fAIfboTI7WUqVjbGZdyVIOomBEMKcd4l-L0CSp9tV5blf4_Y5P9yOH8yCExUf-JS9mHIOY_f_w_e_37mP14wDZatrEJru2jdV04BskeVN6F4LV56CwEYhif-26IYXzEOD7J7d3hYz443c8L_geLsRCW</recordid><startdate>20150512</startdate><enddate>20150512</enddate><creator>Pladys, Adélaïde</creator><creator>Couchoud, Cécile</creator><creator>LeGuillou, Aurélie</creator><creator>Siebert, Muriel</creator><creator>Vigneau, Cécile</creator><creator>Bayat, Sahar</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4500-7869</orcidid></search><sort><creationdate>20150512</creationdate><title>Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients</title><author>Pladys, Adélaïde ; Couchoud, Cécile ; LeGuillou, Aurélie ; Siebert, Muriel ; Vigneau, Cécile ; Bayat, Sahar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cardiovascular diseases</topic><topic>Chronic illnesses</topic><topic>Chronic kidney failure</topic><topic>Comorbidity</topic><topic>Complications and side effects</topic><topic>Death</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 1 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Dialysis</topic><topic>End-stage renal disease</topic><topic>Epidemiology</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Genetics</topic><topic>Health risks</topic><topic>Humans</topic><topic>Insulin resistance</topic><topic>Insulin-like growth factors</topic><topic>Kidney diseases</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney transplantation</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Neoplasms - etiology</topic><topic>Neoplasms - mortality</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Peritoneal dialysis</topic><topic>Peritoneum</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Santé publique et épidémiologie</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Tumors</topic><topic>Type 2 diabetes</topic><topic>Vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pladys, Adélaïde</creatorcontrib><creatorcontrib>Couchoud, Cécile</creatorcontrib><creatorcontrib>LeGuillou, Aurélie</creatorcontrib><creatorcontrib>Siebert, Muriel</creatorcontrib><creatorcontrib>Vigneau, Cécile</creatorcontrib><creatorcontrib>Bayat, Sahar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints Resource Center</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pladys, Adélaïde</au><au>Couchoud, Cécile</au><au>LeGuillou, Aurélie</au><au>Siebert, Muriel</au><au>Vigneau, Cécile</au><au>Bayat, Sahar</au><au>Wong, Germaine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-05-12</date><risdate>2015</risdate><volume>10</volume><issue>5</issue><spage>e0125089</spage><pages>e0125089-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39,811 patients with end-stage renal disease. Their mean age was 67.7±15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p&lt;0.001) and also female gender, peritoneal dialysis, cardio-vascular disease and kidney transplantation were associated with decreased risk of death by cancer. In this French cohort of patients with end-stage renal disease, diabetes was not associated with a significant increased risk of dying from cancer. Studies on the incidence of cancer in patients with ESRD are now needed to evaluate the potential association between diabetes and specific malignancies in this population.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25965806</pmid><doi>10.1371/journal.pone.0125089</doi><orcidid>https://orcid.org/0000-0002-4500-7869</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-05, Vol.10 (5), p.e0125089
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1680430487
source PubMed (Medline); Publicly Available Content Database
subjects Aged
Aged, 80 and over
Analysis
Cancer
Cancer therapies
Cardiovascular diseases
Chronic illnesses
Chronic kidney failure
Comorbidity
Complications and side effects
Death
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Dialysis
End-stage renal disease
Epidemiology
Female
France - epidemiology
Genetics
Health risks
Humans
Insulin resistance
Insulin-like growth factors
Kidney diseases
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - therapy
Kidney transplantation
Life Sciences
Male
Middle Aged
Mortality
Neoplasms - etiology
Neoplasms - mortality
Patient outcomes
Patients
Peritoneal dialysis
Peritoneum
Retrospective Studies
Risk
Risk Factors
Santé publique et épidémiologie
Transplantation
Transplants & implants
Tumors
Type 2 diabetes
Vascular diseases
title Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A20%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%201%20and%20type%202%20diabetes%20and%20cancer%20mortality%20in%20the%202002-2009%20cohort%20of%2039,811%20French%20dialyzed%20patients&rft.jtitle=PloS%20one&rft.au=Pladys,%20Ad%C3%A9la%C3%AFde&rft.date=2015-05-12&rft.volume=10&rft.issue=5&rft.spage=e0125089&rft.pages=e0125089-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0125089&rft_dat=%3Cgale_plos_%3EA431693326%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c726t-1b1510c11e5112837e2cfabe3a2ec15f9baef449ebd349d1943bcf19b33bc6793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1680430487&rft_id=info:pmid/25965806&rft_galeid=A431693326&rfr_iscdi=true